Novocure Ltd
Could not find a ticker for this position, may be a filing error
A maker of wearable, non-invasive cancer therapy devices, Novocure builds portable systems that deliver low-intensity electric fields—called Tumor Treating Fields—to disrupt the division of cancer cells. Its Optune Gio device is used by people with glioblastoma, a form of brain cancer. The company was founded in 2000 by Professor Yoram Palti, a physiology professor who first tested his idea in a laboratory in the basement of his own home. Its name blends "novo" (new) and "cure," reflecting its aim of a fresh approach to treating cancer.
0% Convertible Senior Notes due November 1, 2025
No Schedule 13D or 13G filings recorded.